Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Christine Miossec"'
Autor:
Marisa Haenni, Farid El Garch, Christine Miossec, Jean-Yves Madec, Didier Hocquet, Benoit Valot
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 21, Iss , Pp 57-59 (2020)
Externí odkaz:
https://doaj.org/article/090b51419b304e1ea2e4034aa2a74e58
Autor:
Guerrino Macori, Scott V. Nguyen, Ankita Naithani, Daniel Hurley, Li Bai, Farid El Garch, Frédérique Woehrlé, Christine Miossec, Benjamin Roques, Peadar O’Gaora, James L. Bono, Séamus Fanning
Publikováno v:
Antibiotics, Vol 10, Iss 9, p 1041 (2021)
An antibiotic susceptibility monitoring programme was conducted from 2004 to 2010, resulting in a collection of 143 Escherichia coli cultured from bovine faecal samples (diarrhoea) and milk-aliquots (mastitis). The isolates were subjected to whole-ge
Externí odkaz:
https://doaj.org/article/3d8c42f76ba84476a065dd6e51a9eede
Autor:
Evan Brennan, Marta Martins, Matthew P. McCusker, Juan Wang, Bruno Martins Alves, Daniel Hurley, Farid El Garch, Frédérique Woehrlé, Christine Miossec, Leisha McGrath, Shabarinath Srikumar, Patrick Wall, Séamus Fanning
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 9, Pp 1650-1652 (2016)
Of 150 Escherichia coli strains we cultured from specimens taken from cattle in Europe, 3 had elevated MICs against colistin. We assessed all 3 strains for the presence of the plasmid-mediated mcr-1 gene and identified 1 isolate as mcr-1–positive a
Externí odkaz:
https://doaj.org/article/a46c1a5fc16a41119eb6baea42c36454
Autor:
James L. Bono, Frédérique Woehrlé, Farid El Garch, Scott V. Nguyen, Benjamin Roques, Daniel Hurley, Li Bai, Guerrino Macori, Séamus Fanning, Ankita Naithani, Peadar O'Gaora, Christine Miossec
Publikováno v:
Antibiotics
Antibiotics, Vol 10, Iss 1041, p 1041 (2021)
Volume 10
Issue 9
Macori, G, Nguyen, S V, Naithani, A, Hurley, D, Bai, L, El Garch, F, Woehrlé, F, Miossec, C, Roques, B, O’Gaora, P, Bono, J L & Fanning, S 2021, ' Characterisation of Early Positive mcr-1 Resistance Gene and Plasmidome in Escherichia coli Pathogenic Strains Associated with Variable Phylogroups under Colistin Selection ', Antibiotics, vol. 10, no. 9, 1041 . https://doi.org/10.3390/antibiotics10091041
Antibiotics, Vol 10, Iss 1041, p 1041 (2021)
Volume 10
Issue 9
Macori, G, Nguyen, S V, Naithani, A, Hurley, D, Bai, L, El Garch, F, Woehrlé, F, Miossec, C, Roques, B, O’Gaora, P, Bono, J L & Fanning, S 2021, ' Characterisation of Early Positive mcr-1 Resistance Gene and Plasmidome in Escherichia coli Pathogenic Strains Associated with Variable Phylogroups under Colistin Selection ', Antibiotics, vol. 10, no. 9, 1041 . https://doi.org/10.3390/antibiotics10091041
An antibiotic susceptibility monitoring programme was conducted from 2004 to 2010, resulting in a collection of 143 Escherichia coli cultured from bovine faecal samples (diarrhoea) and milk-aliquots (mastitis). The isolates were subjected to whole-ge
Autor:
Emmanuel Cuinet, Séamus Fanning, Frédérique Woehrlé, Scott V. Nguyen, Farid El Garach, Christine Miossec, Dagmara A. Niedziela, Thomas J Maunsell
Antimicrobial resistance (AMR) has increased at an alarming pace in the recent years. Molecular-based methods such as whole genome sequencing (WGS) offer a potential alternative to the conventional labour-intensive methods traditionally used to chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a02df49b1e733c7ee5c6d15eaf6f843
https://doi.org/10.1101/2021.07.16.452668
https://doi.org/10.1101/2021.07.16.452668
Autor:
Antoine Andremont, G S Crowther, C H Chilton, Mark H. Wilcox, J de Gunzburg, Christine Miossec
Publikováno v:
The Journal of antimicrobial chemotherapy. 75(6)
Background Clostridioides difficile infection (CDI) remains a high burden worldwide. DAV131A, a novel adsorbent, reduces residual gut antimicrobial levels, reducing CDI risk in animal models. Objectives We used a validated human gut model to investig
Autor:
Benoît Valot, Christine Miossec, Jean-Yves Madec, Marisa Haenni, Didier Hocquet, Farid El Garch
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 21, Iss, Pp 57-59 (2020)
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, Elsevier, 2020, 21, pp.57-59. ⟨10.1016/j.jgar.2020.02.016⟩
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, Elsevier, 2020, 21, pp.57-59. ⟨10.1016/j.jgar.2020.02.016⟩
International audience
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:1931-1934
The novel β-lactamase inhibitor avibactam is a potent inhibitor of class A, class C, and some class D enzymes. The in vitro antibacterial activity of the ceftazidime-avibactam combination was determined for a collection of Enterobacteriaceae clinica
Autor:
Charles Burdet, Sakina Sayah-Jeanne, Thu Thuy Nguyen, Christine Miossec, Nathalie Saint-Lu, Mark Pulse, William Weiss, Antoine Andremont, France Mentré, Jean de Gunzburg
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2017, ⟨10.1128/AAC.00543-17⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2017, ⟨10.1128/AAC.00543-17⟩
Lowering the gut exposure to antibiotics during treatments can prevent microbiota disruption. We evaluated the effects of an activated charcoal-based adsorbent, DAV131A, on the fecal free moxifloxacin concentration and mortality in a hamster model of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f469fb9a4e9131713d73661d3941dbe4
https://www.hal.inserm.fr/inserm-01590774/file/20170921_manuscript_HAL.pdf
https://www.hal.inserm.fr/inserm-01590774/file/20170921_manuscript_HAL.pdf
Autor:
Kenneth Coleman, Premavathy Levasseur, Ludovic Lavallade, Christine Miossec, Anne-Marie Girard, John L. Pace
Publikováno v:
Antimicrobial Agents and Chemotherapy. 58:6490-6495
Avibactam is a novel non-β-lactam β-lactamase inhibitor that has been shown in vitro to inhibit class A, class C, and some class D β-lactamases. It is currently in phase 3 of clinical development in combination with ceftazidime. In this study, the